In addition, GSVA analysis revealed that the subgroup of patients with low expression levels of HSPA6 were mainly associated with metabolism-related mechanisms, while the subgroup of patients with high expression levels of HSPA6 were mainly associated with cancer-related signaling pathways and immune responses. Here, HSPA6 is linked to cancer.